@article{2ac6f06371324a79b5e00d86c72a0495,
title = "Anal dysplasia in human immunodeficiency virus-infected men who have sex with men with sexually acquired early hepatitis C virus infection",
abstract = "Background. Human immunodeficiency virus (HIV)-infected men who have sex with men (MSM) are at increased risk of anorectal infection with high-risk human papillomavirus and subsequent high-grade squamous intraepithelial lesions (HSIL), the putative precursor to anal cancer. Recently, an epidemic of sexually transmitted hepatitis C virus (HCV) has emerged that shares this anorectal route of transmission. We hypothesized that the prevalence of anal HSIL would be high in HIV-infected MSM with sexually acquired early HCV infection. Methods. High-resolution anoscopy (HRA) findings from a cohort of HIV-infected MSM with sexually acquired early HCV infection were compared with HRA findings from a contemporary cohort of HIV-infected MSM without HCV infection who underwent HRA due to abnormal anal cytology found during routine screening. Results. Sixty HIV-infected MSM with sexually acquired early HCV infection and the comparator group of 1150 HIV-infected MSM with abnormal anal cytology but without HCV underwent HRA. The HIV-infected MSM with sexually acquired early HCV had higher CD4 counts compared with the comparator group (656 and 541 cells/μL, respectively; P = .02). Despite this, the prevalence of anal dysplasia was as high among MSM with early HCV as in the comparator group of MSM with abnormal cytology (47 [78%] and 941 [82%], respectively; P = .50), as was the proportion with HSIL (25 [42%] and 379 [33%], respectively; P = .17). Conclusions. The prevalence of anal dysplasia in HIV-infected MSM with sexually acquired early HCV infection was as high as that of HIV-infected MSM with abnormal anal cytology. These findings suggest that primary screening with HRA may be warranted for HIV-infected MSM with early HCV.",
keywords = "Anal cancer, Human papilloma virus (HPV), Sexual transmission",
author = "{the New York Acute Hepatitis C Surveillance Network} and Jacobson, {Karen B.} and Gaisa, {Michael M.} and Keith Sigel and Foster, {Andrew L.} and Fierer, {Daniel S.} and Bisher Akil and Juan Bailey and Paul Bellman and Daniel Bowers and Krisczar Bungay and Susanne Burger and Ward Carpenter and Aviva Cantor and Rachel Chasan and Robert Chavez and Rita Chow and Robert Cohen and Patrick Dalton and John Dellosso and Adrian Demidont and Stephen Dillon and Eileen Donlon and Terry Farrow and Jose Fefer and Rodolfo Guadron and Stuart Haber and Susan Hefron and Lawrence Higgins and Lawrence Hitzeman and Ricky Hsu and Shirish Huprikar and Victor Inada and Sneha Jacob and Livette Johnson and Barbara Johnston and Donald Kaminsky and Oscar Klein and Jeffrey Kwong and Jose Lares-Guia and Eric Leach and Randy Levine and Irina Linetskaya and Larisa Litvinova and Amisha Malhotra and William Mandell and Martin Markowitz and Gal Mayer and Eddie Meraz and Erik Mortensen and Steven Rapaport",
note = "Funding Information: Potential conflicts of interest. D. S. F. reports (1) being on the steering committee for, a speaker for, and receiving honoraria from the Chronic Liver Disease Foundation, (2) having been a speaker for and received honoraria from the National Committee for Quality Assurance, and (3) having research funding from, and owning common stock in, Gilead Sciences, Inc. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. Funding Information: Financial support. This work was funded by the National Cancer Institute at the National Institutes of Health (Grant Number K07 CA 180782; to K. S.]. Publisher Copyright: {\textcopyright} The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com",
year = "2019",
month = nov,
doi = "10.1093/ofid/ofz339",
language = "English",
volume = "6",
journal = "Open Forum Infectious Diseases",
issn = "2328-8957",
publisher = "Oxford University Press",
number = "11",
}